Literature DB >> 23926352

Limited nucleotide changes in the Rev response element (RRE) during HIV-1 infection alter overall Rev-RRE activity and Rev multimerization.

Emily A Sloan1, Mary F Kearney, Laurie R Gray, Kathryn Anastos, Eric S Daar, Joseph Margolick, Frank Maldarelli, Marie-Louise Hammarskjold, David Rekosh.   

Abstract

HIV-1 Rev and the Rev response element (RRE) enable a critical step in the viral replication cycle by facilitating the nuclear export of intron-containing mRNAs, yet their activities have rarely been analyzed in natural infections. This study characterized their genetic and functional variation in a small cohort of HIV-infected individuals. Multiple Rev and RRE sequences were obtained using single-genome sequencing (SGS) of plasma samples collected within 6 months after seroconversion and at a later time. This allowed the identification of cognate sequences that were linked in vivo in the same viral genome and acted together as a functional unit. Phylogenetic analyses of these sequences indicated that 4/5 infections were founded by a single transmission event. Rev and RRE variants from each time point were subjected to functional analysis as both cognate pairs and as individual components. While a range of Rev-RRE activities were seen, the activity of cognate pairs from a single time point clustered to a discrete level, which was termed the set point. In 3/5 patients, this set point changed significantly over the time period studied. In all patients, RRE activity was more sensitive to sequence variation than Rev activity and acted as the primary driver of the cognate set point. Selected patient RREs were also shown to have differences in Rev multimerization using gel shift binding assays. Thus, rather than acting as a simple on-off switch or maintaining a constant level of activity throughout infection, the Rev-RRE system can fluctuate, presumably to control replication.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23926352      PMCID: PMC3807272          DOI: 10.1128/JVI.01392-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Deletions near the N-terminus of HIV-1 Rev reduce RNA binding affinity and dominantly interfere with Rev function irrespective of the RNA target.

Authors:  K S Jeong; Y S Nam; S Venkatesan
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

2.  Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype.

Authors:  Prasith Baccam; Robert J Thompson; Yuxing Li; Wendy O Sparks; Michael Belshan; Karin S Dorman; Yvonne Wannemuehler; J Lindsay Oaks; James L Cornette; Susan Carpenter
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  A robust measure of HIV-1 population turnover within chronically infected individuals.

Authors:  G Achaz; S Palmer; M Kearney; F Maldarelli; J W Mellors; J M Coffin; J Wakeley
Journal:  Mol Biol Evol       Date:  2004-06-23       Impact factor: 16.240

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Rev activity determines sensitivity of HIV-1-infected primary T cells to CTL killing.

Authors:  Kevin R Bobbitt; Marylyn M Addo; Marcus Altfeld; Tracey Filzen; Adewunmi A Onafuwa; Bruce D Walker; Kathleen L Collins
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

7.  The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals.

Authors:  M M Addo; M Altfeld; E S Rosenberg; R L Eldridge; M N Philips; K Habeeb; A Khatri; C Brander; G K Robbins; G P Mazzara; P J Goulder; B D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

8.  Structural basis of a phototropin light switch.

Authors:  Shannon M Harper; Lori C Neil; Kevin H Gardner
Journal:  Science       Date:  2003-09-12       Impact factor: 47.728

9.  New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma.

Authors:  Sarah Palmer; Ann P Wiegand; Frank Maldarelli; Holly Bazmi; JoAnn M Mican; Michael Polis; Robin L Dewar; Angeline Planta; Shuying Liu; Julia A Metcalf; John W Mellors; John M Coffin
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

10.  Cytotoxic T-lymphocyte (CTL) responses directed against regulatory and accessory proteins in HIV-1 infection.

Authors:  M M Addo; X G Yu; E S Rosenberg; B D Walker; M Altfeld
Journal:  DNA Cell Biol       Date:  2002-09       Impact factor: 3.311

View more
  17 in total

1.  A cell-penetrating antibody fragment against HIV-1 Rev has high antiviral activity: characterization of the paratope.

Authors:  Xiaolei Zhuang; Stephen J Stahl; Norman R Watts; Michael A DiMattia; Alasdair C Steven; Paul T Wingfield
Journal:  J Biol Chem       Date:  2014-05-30       Impact factor: 5.157

2.  Rev-RRE Functional Activity Differs Substantially Among Primary HIV-1 Isolates.

Authors:  Patrick E Jackson; Denis M Tebit; David Rekosh; Marie-Louise Hammarskjold
Journal:  AIDS Res Hum Retroviruses       Date:  2016-06-03       Impact factor: 2.205

Review 3.  A structurally plastic ribonucleoprotein complex mediates post-transcriptional gene regulation in HIV-1.

Authors:  Jason D Fernandes; David S Booth; Alan D Frankel
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-03-01       Impact factor: 9.957

4.  HIV-1 Rev interacts with HERV-K RcREs present in the human genome and promotes export of unspliced HERV-K proviral RNA.

Authors:  Laurie R Gray; Rachel E Jackson; Patrick E H Jackson; Stefan Bekiranov; David Rekosh; Marie-Louise Hammarskjöld
Journal:  Retrovirology       Date:  2019-12-16       Impact factor: 4.602

5.  Evolution of the HIV-1 Rev Response Element during Natural Infection Reveals Nucleotide Changes That Correlate with Altered Structure and Increased Activity over Time.

Authors:  Chringma Sherpa; Patrick E H Jackson; Laurie R Gray; Kathryn Anastos; Stuart F J Le Grice; Marie-Louise Hammarskjold; David Rekosh
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

6.  Sequence and Functional Variation in the HIV-1 Rev Regulatory Axis.

Authors:  Patrick E H Jackson; Godfrey Dzhivhuho; David Rekosh; Marie-Louise Hammarskjold
Journal:  Curr HIV Res       Date:  2020       Impact factor: 1.581

7.  Human Immunotypes Impose Selection on Viral Genotypes Through Viral Epitope Specificity.

Authors:  Migle Gabrielaite; Marc Bennedbæk; Adrian G Zucco; Christina Ekenberg; Daniel D Murray; Virginia L Kan; Giota Touloumi; Linos Vandekerckhove; Dan Turner; James Neaton; H Clifford Lane; Sandra Safo; Alejandro Arenas-Pinto; Mark N Polizzotto; Huldrych F Günthard; Jens D Lundgren; Rasmus L Marvig
Journal:  J Infect Dis       Date:  2021-12-15       Impact factor: 5.226

Review 8.  HIV Rev Assembly on the Rev Response Element (RRE): A Structural Perspective.

Authors:  Jason W Rausch; Stuart F J Le Grice
Journal:  Viruses       Date:  2015-06-12       Impact factor: 5.048

9.  RNA-directed remodeling of the HIV-1 protein Rev orchestrates assembly of the Rev-Rev response element complex.

Authors:  Bhargavi Jayaraman; David C Crosby; Christina Homer; Isabel Ribeiro; David Mavor; Alan D Frankel
Journal:  Elife       Date:  2014-12-08       Impact factor: 8.140

10.  The export receptor Crm1 forms a dimer to promote nuclear export of HIV RNA.

Authors:  David S Booth; Yifan Cheng; Alan D Frankel
Journal:  Elife       Date:  2014-12-08       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.